IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,350,000 | -10.9% | 33,852 | +0.4% | 0.13% | -17.1% |
| Q1 2021 | $1,515,000 | +3.3% | 33,701 | +29.9% | 0.15% | 0.0% |
| Q4 2020 | $1,466,000 | -38.9% | 25,944 | -48.7% | 0.15% | -41.5% |
| Q3 2020 | $2,398,000 | +11.3% | 50,537 | +38.2% | 0.26% | +6.6% |
| Q2 2020 | $2,155,000 | +323.4% | 36,558 | +725.4% | 0.24% | +248.6% |
| Q1 2020 | $509,000 | +88.5% | 4,429 | -0.8% | 0.07% | +150.0% |
| Q4 2019 | $270,000 | +1.1% | 4,463 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $267,000 | +128.2% | 4,463 | +145.9% | 0.03% | +133.3% |
| Q2 2019 | $117,000 | – | 1,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |